- $45.60m
- $32.61m
- $27.48m
Sensus Healthcare Inc reports results for the quarter ended in September - Earnings Summary
Sensus Healthcare Inc expected to post a loss of 2 cents a share - Earnings Preview
Brief: Chinese Health Authority Renews License For Sensus Healthcare’s SRT-100 For Five More Years
U.S. STOCKS ON THE MOVE-Gannett, FireEye, Novavax Inc
U.S. STOCKS ON THE MOVE-Kaixin Auto, Dicerna Pharma, Yelp
Sensus Healthcare jumps on Q2 revenue beat
Sensus Healthcare Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sensus Healthcare Q2 Revenue Rose 358 Percent To $5.4 Million
Sensus Healthcare Inc expected to post a loss of 5 cents a share - Earnings Preview
Sensus Healthcare Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sensus Healthcare Reports First Quarter 2021 Financial Results
Sensus Healthcare Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Sensus Healthcare Reports Q4 And Full Year 2020 Financial Results
Brief: Sensus Healthcare Granted U.S. Patent For Three-Dimensional Beam Forming X-Ray Source
Brief: Sensus Healthcare - Entered Into Exclusive Distribution Agreement With Ekpac Healthcare Ltd
Brief: Sensus Healthcare Announces Study Showing Single Low Dose Of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision
Brief: Sensus Healthcare Q3 Earnings Per Share Estimate $-0.14 -- Refinitiv Ibes Data
Brief: Sensus Healthcare Appoints Megan Cornish To Its Board Of Directors
Brief: Sensus Healthcare Says Publication Of Study Shows Use Of Superficial Radiation Therapy Post-Keloidectomy Prevents Keloid Recurrence